1. Home
  2. VIR vs MEG Comparison

VIR vs MEG Comparison

Compare VIR & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • MEG
  • Stock Information
  • Founded
  • VIR 2016
  • MEG 2012
  • Country
  • VIR United States
  • MEG United States
  • Employees
  • VIR N/A
  • MEG N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • MEG Professional Services
  • Sector
  • VIR Health Care
  • MEG Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • MEG Nasdaq
  • Market Cap
  • VIR 1.0B
  • MEG 1.0B
  • IPO Year
  • VIR 2019
  • MEG 2020
  • Fundamental
  • Price
  • VIR $9.25
  • MEG $21.99
  • Analyst Decision
  • VIR Buy
  • MEG Buy
  • Analyst Count
  • VIR 5
  • MEG 6
  • Target Price
  • VIR $36.40
  • MEG $38.67
  • AVG Volume (30 Days)
  • VIR 1.3M
  • MEG 569.3K
  • Earning Date
  • VIR 10-31-2024
  • MEG 11-06-2024
  • Dividend Yield
  • VIR N/A
  • MEG N/A
  • EPS Growth
  • VIR N/A
  • MEG N/A
  • EPS
  • VIR N/A
  • MEG N/A
  • Revenue
  • VIR $78,618,000.00
  • MEG $673,079,000.00
  • Revenue This Year
  • VIR N/A
  • MEG $14.37
  • Revenue Next Year
  • VIR N/A
  • MEG $9.73
  • P/E Ratio
  • VIR N/A
  • MEG N/A
  • Revenue Growth
  • VIR N/A
  • MEG 12.56
  • 52 Week Low
  • VIR $7.12
  • MEG $19.59
  • 52 Week High
  • VIR $13.09
  • MEG $49.97
  • Technical
  • Relative Strength Index (RSI)
  • VIR 59.65
  • MEG 36.99
  • Support Level
  • VIR $9.48
  • MEG $19.82
  • Resistance Level
  • VIR $10.13
  • MEG $28.05
  • Average True Range (ATR)
  • VIR 0.59
  • MEG 1.74
  • MACD
  • VIR 0.16
  • MEG -0.52
  • Stochastic Oscillator
  • VIR 64.16
  • MEG 25.62

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

Share on Social Networks: